CLINICAL_TRIALS
trial_result
· 2019-10-04
Clinical Trial Update: Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors [Phase 1]
Summary
Phase 1 study evaluating NGR-hTNF in combination with doxorubicin in solid tumors completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AGC Biologics S.p.A. | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-10-04